Literature DB >> 16325157

Protective effects of nicergoline against neuronal cell death induced by activated microglia and astrocytes.

Tetsuya Mizuno1, Reiko Kuno, Atsumi Nitta, Toshitaka Nabeshima, Guiqin Zhang, Jun Kawanokuchi, Jinyan Wang, Shijie Jin, Hideyuki Takeuchi, Akio Suzumura.   

Abstract

We examined the neuroprotective role of nicergoline in neuron-microglia or neuron-astrocytes co-cultures. Nicergoline, an ergoline derivative, significantly suppressed the neuronal cell death induced by co-culture with activated microglia or astrocytes stimulated with lipopolysaccharide (LPS) and interferon (IFN)-gamma. To elucidate the mechanism by which nicergoline exerts a neuroprotective effect, we examined the production of inflammatory mediators and neurotrophic factors in activated microglia and astrocytes following nicergoline treatment. In microglia stimulated with LPS and IFN-gamma, nicergoline suppressed the production of superoxide anions, interleukin (IL)-1beta, IL-6, and tumor necrosis factor (TNF)-alpha in a dose-dependent manner. In astrocytes, nicergoline also suppressed the production of proinflammatory cytokines and enhanced brain-derived neurotrophic factor (BDNF). Thus, nicergoline-mediated neuroprotection resulted primarily from the inhibition of inflammatory mediators and the upregulation of neurotrophic factors by glial cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16325157     DOI: 10.1016/j.brainres.2005.10.050

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  14 in total

1.  Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage.

Authors:  Jian Wang; Sylvain Doré
Journal:  Brain       Date:  2007-06       Impact factor: 13.501

2.  The therapeutic potential of LRRK2 and alpha-synuclein in Parkinson's disease.

Authors:  Saurabh Sen; Andrew B West
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

3.  Changes in HIF-1α, VEGF, NGF and BDNF levels in cerebrospinal fluid and their relationship with cognitive impairment in patients with cerebral infarction.

Authors:  Xian-Jun Ke; Jun-Jian Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-06-17

Review 4.  Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts.

Authors:  Lisa Fellner; Kurt A Jellinger; Gregor K Wenning; Nadia Stefanova
Journal:  Acta Neuropathol       Date:  2011-05-12       Impact factor: 17.088

Review 5.  Phosphodiesterase Inhibitors for Alzheimer's Disease: A Systematic Review of Clinical Trials and Epidemiology with a Mechanistic Rationale.

Authors:  Owen Sanders; Lekshmy Rajagopal
Journal:  J Alzheimers Dis Rep       Date:  2020-06-16

Review 6.  Glia and alpha-synuclein in neurodegeneration: A complex interaction.

Authors:  Dominik Brück; Gregor K Wenning; Nadia Stefanova; Lisa Fellner
Journal:  Neurobiol Dis       Date:  2015-03-10       Impact factor: 5.996

Review 7.  The role of glia in α-synucleinopathies.

Authors:  Lisa Fellner; Nadia Stefanova
Journal:  Mol Neurobiol       Date:  2012-09-02       Impact factor: 5.590

8.  Disruption of GM2/GD2 synthase gene resulted in overt expression of 9-O-acetyl GD3 irrespective of Tis21.

Authors:  Keiko Furukawa; Wei Aixinjueluo; Takeshi Kasama; Yuki Ohkawa; Michiko Yoshihara; Yusuke Ohmi; Orie Tajima; Akio Suzumura; Daiji Kittaka; Koichi Furukawa
Journal:  J Neurochem       Date:  2008-01-14       Impact factor: 5.372

Review 9.  Proton Pump Inhibitors and Dementia: Physiopathological Mechanisms and Clinical Consequences.

Authors:  Gloria Ortiz-Guerrero; Diana Amador-Muñoz; Carlos Alberto Calderón-Ospina; Daniel López-Fuentes; Mauricio Orlando Nava Mesa
Journal:  Neural Plast       Date:  2018-03-21       Impact factor: 3.599

10.  A primary neural cell culture model to study neuron, astrocyte, and microglia interactions in neuroinflammation.

Authors:  Noah Goshi; Rhianna K Morgan; Pamela J Lein; Erkin Seker
Journal:  J Neuroinflammation       Date:  2020-05-11       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.